David J Yadock

  • Citations Per Year
Learn More
BACKGROUND The infusion of PBSC or BM cells cryopreserved with DMSO is associated with frequent, but generally minor, toxicity. The incidence and severity of infusion-related toxicity is proportional to the amount of DMSO infused. In an attempt to reduce the incidence of symptoms reported by patients receiving cryopreserved PBSC and to avoid the necessity(More)
BACKGROUND AIMS An optimal cooling rate is one of the critical factors influencing the survival of cells during cryopreservation. We describe a novel device, called the box-in-box, that has been developed for optimal cryopreservation of human hematopoietic stem cells (HSC). METHODS This work presents the design of the device, a mathematical formulation(More)
BACKGROUND AIMS Peripheral blood stem cells (PBSC) have become the preferred stem cell source for autologous hematopoietic transplantation. A critical aspect of this treatment modality is cryopreservation of the stem cell products, which permits temporal separation of the PBSC mobilization/collection phase from the subsequent high-dose therapy. While(More)
The cooling process is critical for the cryopreservation of human hematopoietic stem cells (HSCs). Currently, programmed freezing methods and uncontrolled cooling methods are in use, both having obvious disadvantages. In this article, a novel device termed Box-in-Box (BIB) was developed and evaluated by in vitro cryopreservation tests in 2 different(More)
  • 1